Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Sembill S, Ampatzidou M, Chaudhury S, Dworzak M, Kalwak K, Karow A, Kiani A, Krumbholz M, Luesink M, Naumann-Bartsch N, De Moerloose B, Osborn M, Schultz KR, Sedlacek P, Giona F, Zwaan CM, Shimada H, Versluijs B, Millot F, Hijiya N, Suttorp M, Metzler M. Sembill S, et al. Among authors: karow a. Leukemia. 2023 Mar;37(3):505-517. doi: 10.1038/s41375-023-01822-2. Epub 2023 Jan 27. Leukemia. 2023. PMID: 36707619 Free PMC article. Review.
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib.
Häselbarth L, Karow A, Mentz K, Böttcher M, Roche-Lancaster O, Krumbholz M, Jitschin R, Mougiakakos D, Metzler M. Häselbarth L, et al. Among authors: karow a. Cancer Immunol Immunother. 2023 Jun;72(6):1661-1672. doi: 10.1007/s00262-022-03361-8. Epub 2023 Jan 5. Cancer Immunol Immunother. 2023. PMID: 36602564 Free PMC article.
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia.
Behrens YL, Gaschler L, Nienhold R, Reinkens T, Schirmer E, Knöß S, Strasser R, Sembill S, Wotschofsky Z, Suttorp M, Krumbholz M, Schlegelberger B, Metzler M, Göhring G, Karow A. Behrens YL, et al. Among authors: karow a. Haematologica. 2024 Mar 1;109(3):942-947. doi: 10.3324/haematol.2023.283800. Haematologica. 2024. PMID: 37706343 Free PMC article. No abstract available.
Synergistic lethality in chronic myeloid leukemia - targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment.
Häselbarth L, Gamali S, Saul D, Krumbholz M, Böttcher-Loschinski R, Böttcher M, Zou D, Metzler M, Karow A, Mougiakakos D. Häselbarth L, et al. Among authors: karow a. BMC Cancer. 2023 Nov 27;23(1):1153. doi: 10.1186/s12885-023-11623-6. BMC Cancer. 2023. PMID: 38012567 Free PMC article.
Imatinib treatment and longitudinal growth in pediatric patients with chronic myeloid leukemia: Influence of demographic, pharmacological, and genetic factors in the German CML-PAED cohort.
Stiehler S, Sembill S, Schleicher O, Marx M, Rauh M, Krumbholz M, Karow A, Suttorp M, Woelfle J, Maj C, Metzler M. Stiehler S, et al. Among authors: karow a. Haematologica. 2024 Mar 14. doi: 10.3324/haematol.2023.284668. Online ahead of print. Haematologica. 2024. PMID: 38497150 Free article.
Research on Rare Diseases in Germany - The cancer predisposition syndrome registry.
Dutzmann CM, Palmaers NE, Müntnich LJ, Strüwe FJ, Penkert J, Sänger B, Hoffmann B, Karow A, Reimer C, Gerasimov T, Niewisch MR, Kratz CP. Dutzmann CM, et al. Among authors: karow a. J Health Monit. 2023 Dec 13;8(4):17-23. doi: 10.25646/11828. eCollection 2023 Dec. J Health Monit. 2023. PMID: 38384741 Free PMC article.
275 results